Contact Us
Find A Doctor

Denufosol Tetrasodium Injection for Retinal Detachment Study

Principal Investigator

Richard Rosen, M.D.

Enrollment Status 



The purpose of this research study is to determine if administration of denufosol intravitreal injection, an investigational drug not approved by the FDA, is well-tolerated and more efficacious than placebo in stimulating subretinal fluid reabsorption and retinal reattachment without surgical intervention in subjects presenting with rhegmatogenous retinal detachment (RRD).

Study results are currently being analyzed. Please visit this webpage next month for the study update.

For more information:


Contact Us

Dr. Richard Rosen, Principal InvestigatorTel: (212) 979-4284

Katy Tai, Research ManagerTel: (212) 979-4251

Address310 E. 14th StreetNew York, NY 10003

View all locations